↓ Skip to main content

PLOS

An Integrated Computational/Experimental Model of Lymphoma Growth

Overview of attention for article published in PLoS Computational Biology, March 2013
Altmetric Badge

Mentioned by

twitter
12 X users

Citations

dimensions_citation
38 Dimensions

Readers on

mendeley
58 Mendeley
citeulike
1 CiteULike
Title
An Integrated Computational/Experimental Model of Lymphoma Growth
Published in
PLoS Computational Biology, March 2013
DOI 10.1371/journal.pcbi.1003008
Pubmed ID
Authors

Hermann B. Frieboes, Bryan R. Smith, Yao-Li Chuang, Ken Ito, Allison M. Roettgers, Sanjiv S. Gambhir, Vittorio Cristini

Abstract

Non-Hodgkin's lymphoma is a disseminated, highly malignant cancer, with resistance to drug treatment based on molecular- and tissue-scale characteristics that are intricately linked. A critical element of molecular resistance has been traced to the loss of functionality in proteins such as the tumor suppressor p53. We investigate the tissue-scale physiologic effects of this loss by integrating in vivo and immunohistological data with computational modeling to study the spatiotemporal physical dynamics of lymphoma growth. We compare between drug-sensitive Eμ-myc Arf-/- and drug-resistant Eμ-myc p53-/- lymphoma cell tumors grown in live mice. Initial values for the model parameters are obtained in part by extracting values from the cellular-scale from whole-tumor histological staining of the tumor-infiltrated inguinal lymph node in vivo. We compare model-predicted tumor growth with that observed from intravital microscopy and macroscopic imaging in vivo, finding that the model is able to accurately predict lymphoma growth. A critical physical mechanism underlying drug-resistant phenotypes may be that the Eμ-myc p53-/- cells seem to pack more closely within the tumor than the Eμ-myc Arf-/- cells, thus possibly exacerbating diffusion gradients of oxygen, leading to cell quiescence and hence resistance to cell-cycle specific drugs. Tighter cell packing could also maintain steeper gradients of drug and lead to insufficient toxicity. The transport phenomena within the lymphoma may thus contribute in nontrivial, complex ways to the difference in drug sensitivity between Eμ-myc Arf-/- and Eμ-myc p53-/- tumors, beyond what might be solely expected from loss of functionality at the molecular scale. We conclude that computational modeling tightly integrated with experimental data gives insight into the dynamics of Non-Hodgkin's lymphoma and provides a platform to generate confirmable predictions of tumor growth.

X Demographics

X Demographics

The data shown below were collected from the profiles of 12 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 58 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
United States 4 7%
India 1 2%
France 1 2%
Slovenia 1 2%
Unknown 51 88%

Demographic breakdown

Readers by professional status Count As %
Researcher 16 28%
Student > Ph. D. Student 13 22%
Student > Master 5 9%
Student > Postgraduate 4 7%
Professor > Associate Professor 4 7%
Other 10 17%
Unknown 6 10%
Readers by discipline Count As %
Agricultural and Biological Sciences 15 26%
Mathematics 9 16%
Engineering 6 10%
Biochemistry, Genetics and Molecular Biology 5 9%
Computer Science 4 7%
Other 11 19%
Unknown 8 14%